Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Journey Medical (DERM) over the last 4 years, with Q3 2025 value amounting to 0.21%.

  • Journey Medical's Return on Invested Capital changed N/A to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year change of. This contributed to the annual value of 0.34% for FY2024, which is 2900.0% down from last year.
  • Per Journey Medical's latest filing, its Return on Invested Capital stood at 0.21% for Q3 2025.
  • Over the past 5 years, Journey Medical's Return on Invested Capital peaked at 0.08% during Q4 2023, and registered a low of 2.33% during Q4 2021.
  • Moreover, its 4-year median value for Return on Invested Capital was 0.64% (2022), whereas its average is 0.71%.
  • In the last 5 years, Journey Medical's Return on Invested Capital surged by 17200bps in 2022 and then crashed by -300bps in 2023.
  • Over the past 4 years, Journey Medical's Return on Invested Capital (Quarter) stood at 2.33% in 2021, then skyrocketed by 74bps to 0.61% in 2022, then soared by 86bps to 0.08% in 2023, then crashed by -146bps to 0.21% in 2025.
  • Its Return on Invested Capital stands at 0.21% for Q3 2025, versus 0.31% for Q2 2025 and 0.08% for Q4 2023.